Results 191 to 200 of about 97,070 (311)

Exploring glucocorticoid dose-response patterns in VEXAS syndrome: a pilot retrospective study. [PDF]

Rheumatol Int
Giachetti N, Hadjadj J, Gaudré N, Lavigne C, Lacombe V.   +4 more
europepmc   +1 more source

Food Contamination and Safety in Nigeria: A Systematic Synthesis of Heavy Metals, Microbial Pathogens, and Health Risk Metrics

Food Safety and Health, EarlyView.
This is an infographic driver of food contaminants and health effects. ABSTRACT Food safety remains a critical challenge in Nigeria due to rapid urbanization and weak regulatory enforcement. This systematic review synthesizes empirical evidence from 2015 to 2025 to characterize food contaminant profiles and associated human health risks in Nigeria ...
Cecilia Nwadiuto Obasi, Naomi A. Mogborukor, Baridoo Donatus Dooka, Polycarp Dauda Madaki, Chiara Frazzoli, Mohamed Haddad, Orish Ebere Orisakwe   +6 more
wiley   +1 more source

Patterns in topical treatment use for eczema flare-ups in children: a secondary analysis of the Best Emollients for Eczema (BEE) trial. [PDF]

Skin Health Dis
Memory K, MacNeill S, Thomas K, Santer M, Ridd M.   +4 more
europepmc   +1 more source

Integrating Immunotherapy Into Head and Neck Surgery: Bridging Tumor Biology to Perioperative Decision‐Making, a Review

Head &Neck, EarlyView.
ABSTRACT Objective To provide a comprehensive review of the biological rationale, clinical evidence, and practical perioperative management of immunotherapy for the head and neck surgeon. Summary Background Data Standard treatment for resectable head and neck squamous cell carcinoma (HNSCC) has reached a survival plateau, with over 50% of patients ...
Nicholas Brian Shannon, Bruce Ashford
wiley   +1 more source

Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis. [PDF]

J Intern Med
Lend K, Twisk JWR, Koopman FA, Rudin A, Hetland ML, Uhlig T, Nordström DC, Nurmohamed MT, Gudbjornsson B, Hørslev-Petersen K, Heiberg MS, Sokka-Isler T, Grondal G, Haavardsholm EA, Østergaard M, Lampa J, van Vollenhoven R.   +16 more
europepmc   +1 more source

Gout flare burden as a marker of chronic kidney disease risk. [PDF]

BMC Nephrol
Wang HP, Lin CH, Hung PH, Lee C, Chen SC.   +4 more
europepmc   +1 more source

Neoadjuvant Atezolizumab and Chemotherapy for Non‐Squamous Non‐Small Cell Lung Cancer: Efficacy and Safety Results of an Open‐Label, Single‐Arm, Phase II Trial

International Journal of Cancer, EarlyView.
Surgery plus chemotherapy is a well‐established treatment protocol for resectable, locally advanced non‐small cell lung cancer (NSCLC). Nonetheless, survival gains remain limited, emphasizing the need for more effective treatments. Here, the authors evaluated a novel approach using a neoadjuvant immunotherapy‐chemotherapy regimen consisting of ...
Benedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, Raffaella Griffo, Laura V. Klotz, Michael Allgäuer, Albrecht Stenzinger, Helge Bischoff, Marc A. Schneider, Petros Christopoulos, Uwe Haberkorn, Claus Peter Heussel, Inka Zoernig, Felix J. F. Herth, Michael Thomas, Alexander Rölle, Hauke Winter, Axel Benner, Dirk Jaeger, Martin E. Eichhorn   +19 more
wiley   +1 more source

Multiwavelength Multipoint Observations of the October 28, 2021 Type III Radio Burst. [PDF]

Sol Phys
Martinez Oliveros JC, Krupar V, Ervin T, Krucker S, Pulupa M, Badman ST, Buitrago Casas JC, Mondal S, Bale SD.   +8 more
europepmc   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar, Ahmad Badeghiesh, Haitham Baghlaf, Michael H. Dahan   +3 more
wiley   +1 more source

Peritoneal dialysis in lupus nephritis: comparative outcomes vs. hemodialysis, risk stratification, and modality selection framework. [PDF]

Ren Fail
Cheng S, Peng D, Wang X, Yu L, Ren G, Zhang Z, Liu Z.   +6 more
europepmc   +1 more source